CHIR-258, a novel, multitargeted tyrosine kinase inhibitor for the potential treatment of t(4;14) multiple myeloma. (Q40480723)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CHIR-258, a novel, multitargeted tyrosine kinase inhibitor for the potential treatment of t(4;14) multiple myeloma. |
scientific article |
Statements
1 reference
CHIR-258, a novel, multitargeted tyrosine kinase inhibitor for the potential treatment of t(4;14) multiple myeloma. (English)
1 reference
Suzanne Trudel
1 reference
Marion Wiesmann
1 reference
Zhi Hua Li
1 reference
Ellen Wei
1 reference
Hong Chang
1 reference
Christine Chen
1 reference
Donna Reece
1 reference
Carla Heise
1 reference
A Keith Stewart
1 reference
14 December 2004
1 reference
Identifiers
1 reference